New forms and future perspectives in endocrine treatment of prostatic carcinoma.
D000616:Aminoglutethimide / Q000627:therapeutic use; D000726:Androgen Antagonists / Q000627:therapeutic use; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005485:Flutamide / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010906:Pituitary Hormone-Releasing Hormones / Q000627:therapeutic use; D011388:Prolactin / Q000037:antagonists & inhibitors; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists; D004965:Estrogen Antagonists; D006728:Hormones; D010906:Pituitary Hormone-Releasing Hormones; D000616:Aminoglutethimide; D017373:Cyproterone Acetate; D005485:Flutamide; D011388:Prolactin; D003534:Cyproterone